API and intermediates are one of the main businesses of our company, and are short-term projects of the company. They can obtain economic income as soon as possible, so as to maintain the normal operation and to support the new drug research and development of our company. The company is mainly engaged in the process development and industrialization, technology transfer and consulting services of APIs and key intermediates with high difficulty and technical differences.